Pharma & Biotech

Bruker Corporation faces mounting pressure as market analysts maintain a cautious stance on the scientific instrument maker's shares. The prevailing...

As pharmaceutical companies compete to develop the next generation of breakthrough treatments, Incyte appears to be positioning a potentially significant...

Biopharmaceutical firm Denali Therapeutics finds itself navigating a turbulent period in the markets. Despite reporting significant progress in its clinical...

The curtain has fallen on Walgreens Boots Alliance's tenure as a publicly traded entity. Private equity firm Sycamore Partners has...

Replimune Group Inc. finds itself navigating turbulent market conditions as its stock value experiences a dramatic collapse. The biotechnology firm...

Investors in Liquidia Corporation are bracing for a pivotal moment as the biotechnology company prepares to unveil significant clinical trial...

Investors showed renewed confidence in Capricor Therapeutics last week following a significant regulatory development from the U.S. Food and Drug...

A recent analyst report dated September 29 has cast a favorable light on Aldeyra Therapeutics, identifying the biotechnology company as...

The biotechnology leader Amgen presents investors with a puzzling scenario. Despite announcing substantial capital investments and reporting robust quarterly earnings,...

The animal health sector leader Zoetis finds itself navigating turbulent market conditions, presenting investors with a perplexing scenario. While the...